Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(50%)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Terminated(2)
Other(1)

Detailed Status

Terminated2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown125%
terminated250%
not_yet_recruiting125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Using the Accuvein Device for Patients Who Are Difficult to Perfuse

NCT06861595
unknownnot_applicable

Infrared for Peripheral Venous Catheterization in the Critically-ill

NCT03932214
terminatednot_applicable

Evaluation of Accuvein in Obese Patients

NCT02015845
terminatedphase_4

Evaluation of Accuvein in Adult Patients

NCT01020461

Clinical Trials (4)

Showing 4 of 4 trials
NCT06861595Not Applicable

Using the Accuvein Device for Patients Who Are Difficult to Perfuse

Not Yet Recruiting
NCT03932214Not Applicable

Infrared for Peripheral Venous Catheterization in the Critically-ill

Unknown
NCT02015845Not Applicable

Evaluation of Accuvein in Obese Patients

Terminated
NCT01020461Phase 4

Evaluation of Accuvein in Adult Patients

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4